Reuters Health Report

Click to View in Browser 02/5/2014 India's Ranbaxy faces more regulatory scrutiny after U.S. ban MUMBAI (Reuters) - Ranbaxy Laboratories Ltd has been hit by more regulatory scrutiny sparked by a U.S. ban on the bulk of its drugs, in a backlash that could bump up compliance costs and erode profitability among some Indian makers of generic drugs. CVS to become first major U.S. drugstore chain to drop cigarettes (Reuters) - CVS Caremark Corp said on Wednesday that it would stop selling tobacco products at its 7,600 stores by October, becoming the first national drugstore chain in the United States to take cigarettes off the shelf. GlaxoSmithKline forecasts better 2014 as drug R&D improves LONDON (Reuters) - GlaxoSmithKline has predicted a pick-up in sales growth to around 2 percent this year as productivity in its drug research labs improves and pressure on sales in China moderates following a damaging bribery scandal. Ipsen says to seek approval for muscle-spasm drug PARIS (Reuters) - French drugmaker Ipsen said that it would begin the process of regulatory approval for a muscle-spasm drug, branded Dysport Next Generation, after a liquid-toxin trial showed it was "safe and efficacious". Merck results flag, but cancer-drug deals lift shares (Reuters) - Merck & Co Inc's quarterly profit and sales just missed expectations as its medicines faced competition from cheaper generics, but shares rose 1.5 percent on enthusiasm for newly announced cancer-drug partnerships with rival U.S. companies. Parents often underestimate children's weight: study NEW YORK (Reuters Health) - Half of parents with an overweight or obese child think their kids are slimmer than they actually are, according to a new review of past studies. Alcohol-linked deaths a problem for the Americas NEW YORK (Reuters Health) - Liver disease and brain disorders due to alcohol abuse are important causes of premature death in the Americas, a new study concludes. Study warns some lubricants could block conception NEW YORK (Reuters Health) - Couples trying to conceive may want to avoid using certain common sexual lubricants, which a new study says can harm sperm and reduce the chances of pregnancy. New China bird flu a reminder of mutant virus risk LONDON (Reuters) - The death of a woman in China from a strain of bird flu previously unknown in humans is a reminder of the ever-present potential pandemic threat from mutating animal viruses, scientists said on Wednesday. Boston Scientific sees opportunity in rival's setback (Reuters) - Medtronic Inc's stumble in its U.S. medical device study to treat high blood pressure could create an opportunity for other device makers to pick up where their rival has left off, Boston Scientific Corp Chief Executive Mike Mahoney said on Tuesday. Related Video Aftershock compounds earthquake damage to Greek island Keystone pipeline review shows little climate risk The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend